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Abstract
Background: Bioinformatics and medical informatics are two research fields that serve the needs of different but related
communities. Both domains share the common goal of providing new algorithms, methods and technological solutions
to biomedical research, and contributing to the treatment and cure of diseases. Although different microarray techniques
have been successfully used to investigate useful information for cancer diagnosis at the gene expression level, the true
integration of existing methods into day-to-day clinical practice is still a long way off. Within this context, case-based
reasoning emerges as a suitable paradigm specially intended for the development of biomedical informatics applications
and decision support systems, given the support and collaboration involved in such a translational development. With
the goals of removing barriers against multi-disciplinary collaboration and facilitating the dissemination and transfer of
knowledge to real practice, case-based reasoning systems have the potential to be applied to translational research mainly
because their computational reasoning paradigm is similar to the way clinicians gather, analyze and process information
in their own practice of clinical medicine.
Results: In addressing the issue of bridging the existing gap between biomedical researchers and clinicians who work in
the domain of cancer diagnosis, prognosis and treatment, we have developed and made accessible a common interactive
framework. Our geneCBR system implements a freely available software tool that allows the use of combined techniques
that can be applied to gene selection, clustering, knowledge extraction and prediction for aiding diagnosis in cancer
research. For biomedical researches, geneCBR expert mode offers a core workbench for designing and testing new
techniques and experiments. For pathologists or oncologists, geneCBR diagnostic mode implements an effective and
reliable system that can diagnose cancer subtypes based on the analysis of microarray data using a CBR architecture. For
programmers, geneCBR programming mode includes an advanced edition module for run-time modification of previous
coded techniques.
Conclusion: geneCBR is a new translational tool that can effectively support the integrative work of programmers,
biomedical researches and clinicians working together in a common framework. The code is freely available under the
GPL license and can be obtained at http://www.genecbr.org.
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Recent studies in human cancer have demonstrated that
microarrays can be used to develop a new taxonomy of
cancer, including major insights into the genesis, progres-
sion, prognosis, and response to therapy based on gene
expression profiles [1]. However, there continues to be a
need to develop new approaches to (i) diagnose cancer
early in its clinical course, (ii) more effectively treat
advanced stage diseases, (iii) better predict a tumor's
response to therapy prior to the actual treatment, and (iv)
ultimately prevent the appearance of the disease through
chemopreventive strategies. Given that systematic classifi-
cation of tumor types is crucial to achieving advances in
cancer treatment, different machine learning and statisti-
cal techniques have been successfully applied for cancer
classification at the gene expression level. These methods
include the successful application of neural networks [2],
classification trees and mixture models [3], hierarchical
clustering [4], support vector machines [5], shrunken cen-
troids [6,7], compound covariate [8], partial least square
[9], principal component analysis disjoint models [10],
factor mixture models [11], consensus analysis of multi-
ple classifiers using non-repetitive variables [12], diagonal
quadratic discriminant analysis with generalized rule
induction [13] etc.
However, while tremendous effort has been invested dur-
ing recent years in improving the accuracy of novel and
existing methods and techniques, minimal effort has been
put into developing tools concerned with the application
of informatics theory and methods to translational
research. As a result, most informatics systems in use
today are inadequate in terms of handling the tasks of
complicated operations and the management and analy-
sis of contextual data input. In this context, case-based
reasoning (CBR) systems are particularly applicable to the
domain of translational medicine because they (i) sup-
port a rich and evolvable representation of experiences/
problems, solutions and feedback, (ii) provide efficient
and flexible ways to retrieve existing data, and (iii) can
apply analogical reasoning to solve new problems [14].
The research of [15] suggested that analogical reasoning is
particularly applicable to the biological domain, partly
because biological systems are often homologous (rooted
in evolution). Moreover, clinicians often use a form of
reasoning similar to CBR, where experiments are designed
and performed based on the similarity between features of
a new system and those of previously known systems.
In this sense, the research of [16] proposes a mixture of
experts for case-based reasoning (MOE4CBR). Previously,
[17] showed their initial research in applying a CBR
approach to the problem of gene-finding in mammalian
DNA. Previously successful research in the same area
using CBR was carried out by Shavlik [18]. Lieber and
Bresson showed how their CASIMIR/CBR system was able
to suggest solutions for breast cancer treatment by adapt-
ing the rules of a previous rule-based system [19]. Jurisica
and Glasgow demonstrate how case-based reasoning can
be applied to assist in analyzing genomic sequences and
determining the structure of proteins [14]. They also pro-
vide an overview of several other applications in molecu-
lar biology that have benefited from CBR.
In this paper we present geneCBR, a translational tool for
multiple-microarray analysis and integrative information
retrieval for aiding diagnosis in cancer research. The appli-
cation is intended to be used by three different kinds of
users with distinct but related objectives working on the
same problem: the systematic classification of tumor
types.
Implementation
geneCBR was conceived in order to support integrative
work for interdisciplinary research groups working
together to design, implement and test new techniques for
supervised and unsupervised cancer classification and
Translational conception of geneCBR systemFigure 1
Translational conception of geneCBR system. The 
tree-layer architecture of geneCBR supports the collabora-
tive work of programmers, biomedical researches and clini-
cians using the same framework.Page 2 of 8
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ture:
• Clinicians: geneCBR (diagnostic mode) implements an
effective and reliable system for pathologists or oncol-
ogists that can diagnose cancer subtypes based on the
analysis of microarray data using an underlying CBR
architecture.
• Biomedical researches: geneCBR (expert mode) offers a
core workbench for designing and testing new tech-
niques and experiments. It also includes a wizard
capable of generating a preconfigured and easy-to-use
tool for clinicians.
• Programmers: geneCBR (programming mode) includes
an advanced edition module for run-time modifica-
tion of previous coded techniques based on BeanShell
project http://www.beanshell.org/.
geneCBR is implemented as a DB-free Java GUI stan-
dalone application that can run without any other soft-
ware requirements (databases, third-party software, etc.)
except for a Java Runtime Environment (JRE). Because of
the mobility of Java language, the whole system can be
launched in different platforms without restraint. The
application was tested in both Intel Pentium/Core 2 Duo/
Xeon and AMD Athlon CPUs on Windows XP/Vista,
Ubuntu Linux 8.04 version and Max OSX 10.5 with Intel
architecture and Java 1.5 run-time environment installed.
With regards to the translational nature of geneCBR, it
supports three operation modes: expert mode, diagnostic
mode and programming mode.
Expert Mode
Figure 2 shows the logical processing pipeline and data
workflow available in geneCBR expert mode. The software
exhibits several unique presentations and user-friendly
elements by following five simple steps: input data, pre-
processing, gene selection, clustering and deployment
[see Additional file 1 for a detailed explanation]. Moreo-
ver, geneCBR incorporates two advanced modules (Log
module and NetExplorer DB Query) that are available
during the design, test, and deployment of the preconfig-
ured application for geneCBR diagnostic mode operation.
Step 1: Loading microarray data
geneCBR can load microarray gene expression datasets
stored in the form of case bases. A case base holds infor-
mation about the gene values (also called "features") of
various patients (also called "exemplars") with a given (or
unknown) disease type. These raw data are structured into
an open text-based, comma-separated file which also con-
tains meta-data information about each patient (age, sex,
karyotype, observations, etc.) [see Additional file 1 for
technical documentation].
Each loaded case base is graphically displayed showing
both raw data and meta-data information using two avail-
able representations: a tabular view and a raw intensities
colored view. The application also provides the option of
showing only those pathologies of interest.
Step 2: Case base pre-processing
After uploading and visualizing the case base, the micro-
array samples or gene groups to be excluded in later anal-
yses can be filtered from the existing data by creating a
new refined case base. The selected exemplars and features
can also be saved into a different geneCBR case base file.
Additionally, the application provides a built-in opera-
tion to normalize gene expression values.
In order to correctly handle the enormous amount of data
loaded and processed in steps 1–2, geneCBR implements
an advanced internal swapping architecture capable of
supporting as many loaded case bases as needed by
silently transferring data between memory and massive
storage devices.
Step 3: Gene selection and noise filtering
geneCBR provides an implementation of a discriminant
analysis module (DFP) capable of performing fuzzy codi-
geneCBR logical processing pipeline and data workflowFigure 2
geneCBR logical processing pipeline and data work-
flow. The modular design of the system makes it easy to 
include new analyses. Furthermore, it is possible to run only 
specific parts of the pipeline.Page 3 of 8
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whole algorithm comprises three main phases involving
(i) the calculation of different fuzzy membership func-
tions for each gene, (ii) the computation of the corre-
sponding discretized gene expression values and (iii) the
identification of a fuzzy pattern representing the gene
expression signature of each disease.
Once the user completes three previous phases, geneCBR
constructs a discriminant fuzzy pattern by intersecting
gene expression signatures in order to select a final set of
discriminative genes. The result from this operation will
generate a new case base containing only informative
genes (those genes able to discern a specific disease type
from others).
Step 4: Patient clustering
geneCBR implements an unsupervised clustering module
that incorporates a GCS neural network [21] able to group
together all patients that are genetically similar according
to the case base generated in step 3 [22]. Since such net-
works contain explicit distance information, they can be
used effectively to (i) represent an indexing structure
which indexes sets of related patients and (ii) to serve as a
similarity measurement between individual patients.
Once the network is trained, geneCBR stores the model
which can be tested by using a new case base that incorpo-
rates unseen exemplars.
Step 5: Deployment of geneCBR diagnostic mode
Every time the biomedical research group finishes its work
by configuring, testing and tuning the implemented tech-
niques, the application provides a 4-step guided wizard to
setup geneCBR in diagnostic mode [see Additional file 1].
With this configuration, geneCBR is ready to receive a new
sample (microarray experiment) and perform all the pro-
grammed analysis in a single step, providing the clinician
with an adequately substantiated final diagnosis.
Advanced plugins: NetExplorer DB Query and Log module
The practice of biomedical research seeks to comprehend
the intricacy of complex organisms, or their subsystems,
by combining many different kinds of data to improve
existing knowledge. In addition to the previously com-
mented functionalities, geneCBR includes a NetExplorer
DB Query module capable of gathering additional infor-
mation (gene annotations, public gene IDs, biological
functions, relevant related articles from PubMed/
MedLine, etc.) about interesting gene sets (see Figure 3).
This functionality is implemented using geneCBR internal
microarray descriptors constructed from the Affymetrix
web site [see Additional file 1]. geneCBR always keeps its
local files updated by downloading new information as
soon as it is available in Internet.
In order to track all the activity carried out by the different
techniques implemented in our tool, geneCBR incorpo-
rates a Log module that always keeps the user updated
with relevant information about the results obtained.
Diagnostic Mode
Case-based reasoning is a computational reasoning para-
digm that involves the storage and retrieval of past experi-
ences to solve new problems. In diagnostic mode,
geneCBR employs a previously generated case-based rea-
soning system that incorporates a discriminant fuzzy pat-
tern for the retrieval of relevant genes, a growing cell
structure network for the clustering of similar patients and
a proportional weighted voting algorithm to provide an
accurate diagnosis. Figure 4 shows the geneCBR life cycle
that is automatically launched every time the expert needs
to classify a new patient.
While retrieve and reuse phases (showed in Figure 4) are
automatically executed, in the revise phase the expert is
provided with useful information about the initial classi-
fication made by the system and a final decision is
required [see Additional file 2]. The information provided
by the system contains the selected group genes (DFP),
the clustering of patients made by the GCS network, and
the weights assigned to each class. The expert contrasts the
initial prediction given by the system with other external
information like patient karyotype or clinical history in
order to ascertain a revised prediction and a final diagno-
sis. In the retain phase, every time a new classification is
generated, the knowledge base of geneCBR is updated and
the new microarray is associated to its corresponding class
and added to the case base.
Programming Mode
In order to support programmers who work in collabora-
tion with biomedical researches, geneCBR integrates the
GSH (geneCBR shell) console available in geneCBR expert
mode. The GSH console allows scripting in Java language
and supports a wide variety of functionalities including,
but not limited to, rapid prototyping, user scripting exten-
sion, rules engines, configuration, testing, dynamic
deployment, embedded algorithms, etc.
The GSH console is based on the BeanShell project, a
small, free, embeddable Java source interpreter with
object scripting language features. BeanShell dynamically
executes standard Java syntax and extends it with com-
mon scripting conveniences such as loose types, com-
mands, and method closures.
By utilizing the GSH console, the programmer can easily
code new scripts with the goal of preparing and testing
novel techniques and experiments provided by the bio-Page 4 of 8
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implemented in the GSH console, it can be rapidly inte-
grated in geneCBR expert and diagnostic modes. Figure 5
shows a sample code of a GSH script performing a 5-fold
cross-validation.
geneCBR scripts can be directly typed or pasted in the GSH
console, or they can be loaded from a file with .gsh exten-
sion. The functionality of executing those scripts is only
available in geneCBR expert mode.
Results and Discussion
The concept of translational research has received very
strong focus in the biomedical community over the last
few years as a new way of thinking about and conducting
life sciences research to accelerate healthcare outcomes.
However, in order to fully accomplish its objectives, trans-
lational research requires clinicians, researchers and the
various operational staff to be capable of working together
effectively.
Although there are a great number of successful methods
and techniques that can be applied to the discovery of
cancer subtypes using microarray data [23], none of the
implemented tools deals with the translational nature of
the problem that we consider essential for the target inter-
disciplinary research community. For this reason, our
geneCBR system is specifically intended to bridge the
existing gap between basic research and applied research,
and support the collaborative work of biomedical
researchers and clinicians by implementing a common
framework of interaction. In this respect, geneCBR is, as
far as we know, the only application able to aid in the
diagnosis of cancer research from this translational per-
spective.
Moreover, a number of desirable characteristics should be
satisfied in order for a particular tool or system to be con-
sidered for intensive use in the domain of translational
medicine. First, it must be freely available for download
and local installation without any restrictions regarding
geneCBR expert mode functionalitiesFigure 3
geneCBR expert mode functionalities. In expert mode, geneCBR allows biomedical researches by performing multiple-
microarray analysis and integrative information retrieval using its implemented techniques. The application also incorporates an 
extensive context help feature and an easy to follow 4-step wizard to setup geneCBR in diagnostic mode.Page 5 of 8
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should be based, when possible, on freely-available,
open-sourced, successful methods, techniques or method-
ologies. All the functionalities provided by geneCBR,
except for our proposed DFP method, are based on such
tools. Third, regarding software memory requirements, an
efficient usage of available resources is mandatory. As
such, geneCBR implements an advanced internal swap-
ping architecture capable of supporting as many loaded
case bases and analyses as needed. Fourth, geneCBR
includes all the necessary steps for multiple-microarray
analysis with the goal of aiding diagnosis in cancer
research, i.e., pre-processing, gene selection, clustering
and classification, arranged in a sequential, completely
automated pipeline in diagnostic mode. Fifth, with
regards to data mining and knowledge extraction,
geneCBR offers the NetExplorer DB Query advanced mod-
ule, which integrates several widely spread standard
sources of information, thus making it possible to retrieve
relevant information about selected groups of genes.
geneCBR has been tested using several publicly available
microarray datasets related to different pathologies of can-
cer [24,25]. The results provided by geneCBR have con-
firmed that affected genes published by the original
authors are relevant in classifying unknown patients. Sev-
eral examples can be found and replicated using the sam-
ple data and manuals distributed with the geneCBR
application.
The geneCBR project also makes available a web site con-
taining valuable information for the research community.
The home section introduces the tool and gives informa-
tion about case-based reasoning systems. In the download
section, we have developed multiplatform installers for
Windows and Mac/Linux users together with a step-by-
step installation guide. Expert mode and diagnostic mode
tutorials are also available as separate documents along
with sample datasets and a CBR configuration file. The
demo section presents several videos about the utilization
of different functionalities belonging to the geneCBR log-
ical processing pipeline and data workflow.
Conclusion
We developed geneCBR with the goal of providing trans-
lational support to the integrative work of programmers,
biomedical researches and clinicians working together in
a common framework. The application implements a set
of combined techniques that can be applied to gene selec-
tion, clustering, knowledge extraction and prediction for
aiding diagnoses in cancer research. geneCBR offers a set
of core modules and features that are not currently availa-
ble in other biomedical decision support systems. The
application is written entirely in Java 1.5 and is portable
across multiple operating systems and platforms. No
hardware or memory restrictions are imposed by this soft-
ware. It is well documented and simple to execute through
the utilization of the provided installation wizard [see
Additional file 3].
Although the numerical analysis of microarray data is
considerably consolidated, the true integration of numer-
ical analysis and biological knowledge is still a long way
off [26]. The future of geneCBR involves the inclusion of
additional knowledge sources in the classification proc-
ess. This functionality can prevent the discovery of the
obvious data-inferred hypothesis that references previ-
ously proposed relationships, and through its analysis
help avoid overconfident predictions, thus allowing
experts to systematically relate the analysis findings to
present knowledge [27]. In this regard, our goal is to pave
the way for the principled integration of imperfect biolog-
ical knowledge with gene expression data and other high-
throughput data sources in order to make predictions that
are easy to interpret in concert with incorporated knowl-
edge.
geneCBR life cycle working in diagnostic modeFigure 4
geneCBR life cycle working in diagnostic mode. The 
execution starts by searching the case base and retrieving 
the most informative genes with the new microarray sample 
to classify. The selected genes are reused to train a GCS 
network for clustering existing patients, and an initial classifi-
cation is automatically generated. This solution is manually 
revised by the expert and finally, the new case (i.e. the prob-
lem description together with the obtained classification) is 
retained in the case base for future use.Page 6 of 8
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open and evolving project. The application is free, as it has
been released under the GPL license, and its development
is open and collaborative. Researchers are free to use it, to
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optimized configuration that can automatically classify new samples in 
Diagnostic Mode.




Diagnostic Mode manual. This document will guide the user through a 
step by step tutorial showing the capabilities of geneCBR to automatically 
classify new microarray samples in Diagnostic Mode.




Installation guide. This manual covers the installation of geneCBR and 
its related components through the utilization of an installation wizard.
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